Results 101 to 110 of about 4,616 (237)

Nasolabial Flaps in the Treatment of MRONJ [PDF]

, 2019
Nima Mahdian, Eitan Brizman, Anna Onderková, G. Pavlíková   +3 more
openalex   +1 more source

Treatment of Medication-Related Osteonecrosis of the Jaws (MRONJ) with Topical Therapy Using Active Oxygen Gel

Clinical, Cosmetic and Investigational Dentistry
Medication-related osteonecrosis of the jaw (MRONJ) can be a debilitating complication that can arise in patients who took or are taking antiresorptive (including bisphosphonates) or antiangiogenic agents, leading to visible bone or a fistula that ...
T. Deliberador, Carlos Stutz, E. Sartori, Leandro Kluppel, Rubens Moreno de Freitas   +4 more
semanticscholar   +1 more source

Cumulative incidence and risk factors for medication-related osteonecrosis of the jaw during long-term prostate cancer management

Scientific Reports
Bone-modifying agents (BMA) are extensively used in treating patients with prostate cancer with bone metastases. However, this increases the risk of medication-related osteonecrosis of the jaw (MRONJ).
Masaru Tani, Koji Hatano, Akihiro Yoshimura, Yuki Horibe, Yutong Liu, Nesrine Sassi, Toshiki Oka, Yohei Okuda, Akinaru Yamamoto, Toshihiro Uemura, Gaku Yamamichi, Yu Ishizuya, Yoshiyuki Yamamoto, Taigo Kato, Atsunari Kawashima, Norio Nonomura   +15 more
doaj   +1 more source

Preclinical models of medication-related osteonecrosis of the jaw (MRONJ)

, 2021
J. Ignacio Aguirre, Evelyn J. Castillo, Donald B. Kimmel   +2 more
openalex   +2 more sources

Early detection of medication-related osteonecrosis of the jaw (MRONJ) in patients with metastatic breast cancer using FDG-PET/CT scansResearch in context

EClinicalMedicine
Summary: Background: Patients with osseous metastatic breast cancer receive bone-modifying agents (BMAs) as part of their standard care. Medication-related osteonecrosis of the jaw (MRONJ) is one of the most important toxicities of this class of drugs ...
Miriam Emmelheinz, Daniel Egle, Samira Abdel Azim, Angela Augustin, Florentina Baumgart, Benjamin Walch, Johannes Laimer, Emanuel Bruckmoser, Lisa-Maria Rossetti, Steffen Bayerschmidt, Christian Uprimny, Marjan Arvandi, Uwe Siebert, Christian Marth, Christine Brunner   +14 more
doaj   +1 more source

Review of: "Long-Term Risk of Medication-Related Osteonecrosis of the Jaw (MRONJ) After Bisphosphonates and/or Denosumab in Metastatic Breast Cancer Patients" [PDF]

Nazım Can Demircan
openalex   +3 more sources

Hyperbaric Oxygen and Medication-Related Osteonecrosis of the Jaw (MRONJ): An Integrative Review [PDF]

, 2021
Mariel Ruivo Biancardi, Luiz Alberto Valente Soares-Junior, Izabel Regina Fischer Rubira‐Bullen, Paulo Sérgio da Silva Santos   +3 more
openalex   +1 more source

Clinical Performance of Implant-Supported Prostheses in the Rehabilitation of Patients Previously Treated for Medication-Related Osteonecrosis of the Jaws (MRONJ): A Systematic Review

Cureus
There is a lack of consensus on managing resultant bone and soft tissue defects or on restoring oral function and aesthetics following medication-related osteonecrosis of the jaws (MRONJ) lesion healing.
E. Anitua, M. Alkhraisat, A. Eguia
semanticscholar   +1 more source

Regulating Macrophage Polarization Promotes BMSC Homing For MRONJ Prevention

International Dental Journal
Aim or purpose: Bisphosphonates, widely used for osteoporosis and bone metastases, may cause medication-related osteonecrosis of the jaw (MRONJ). This study investigates the role of macrophage polarization and bone marrow-derived mesenchymal stem cell ...
Liru Hu, Jian Pan, Chengzhi Zhao
doaj   +1 more source

MRONJ ASSOCIATED WITH DENTAL INFECTION AND SECONDARY INVOLVEMENT OF THE NEARBY IMPLANT: A CASE REPORT [PDF]

, 2021
Stefania Nespoli, Elisabetta Audino, Stefano Négrini, Francesco Daleffe, Magda Mensi, A. Castellani, Luca Visconti, Stefano Salgarello   +7 more
openalex   +1 more source